As of August 6, 2026, the CDC has confirmed 2,465 measles cases in the United States for the year, already exceeding the full 2025 total of 2,289 and marking the highest annual figure since 1991. Nearly all cases (94%) link to 38 ongoing or extended outbreaks across 47 jurisdictions, driven primarily by transmission among unvaccinated or under-vaccinated individuals amid declining MMR coverage. Recent weekly increments of 24–78 cases indicate steady but not explosive growth, with geographic spread in states like Utah, Arizona, and others sustaining momentum through August. CDC surveillance updates, typically released mid-week, along with any new outbreak declarations, will provide the key data points influencing final tallies by the August 31 resolution window. Trader sentiment reflects these verified case trajectories and epidemiological patterns rather than projections.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoMeasles cases in U.S. by August 31?
Measles cases in U.S. by August 31?
NOWE
Aug 31, 2026
2500+
98%
2550+
92%
2600+
86%
$7,637 Wol.
2500+
$418 Wol.
98%
2550+
$932 Wol.
92%
2600+
$3,344 Wol.
86%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of August 6, 2026, the CDC has confirmed 2,465 measles cases in the United States for the year, already exceeding the full 2025 total of 2,289 and marking the highest annual figure since 1991. Nearly all cases (94%) link to 38 ongoing or extended outbreaks across 47 jurisdictions, driven primarily by transmission among unvaccinated or under-vaccinated individuals amid declining MMR coverage. Recent weekly increments of 24–78 cases indicate steady but not explosive growth, with geographic spread in states like Utah, Arizona, and others sustaining momentum through August. CDC surveillance updates, typically released mid-week, along with any new outbreak declarations, will provide the key data points influencing final tallies by the August 31 resolution window. Trader sentiment reflects these verified case trajectories and epidemiological patterns rather than projections.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Rynek otwarty: Jul 31, 2026, 12:30 PM ET
Wolumen
$7,637Data zakończenia
Aug 31, 2026Rynek otwarty
Jul 31, 2026, 12:30 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of August 6, 2026, the CDC has confirmed 2,465 measles cases in the United States for the year, already exceeding the full 2025 total of 2,289 and marking the highest annual figure since 1991. Nearly all cases (94%) link to 38 ongoing or extended outbreaks across 47 jurisdictions, driven primarily by transmission among unvaccinated or under-vaccinated individuals amid declining MMR coverage. Recent weekly increments of 24–78 cases indicate steady but not explosive growth, with geographic spread in states like Utah, Arizona, and others sustaining momentum through August. CDC surveillance updates, typically released mid-week, along with any new outbreak declarations, will provide the key data points influencing final tallies by the August 31 resolution window. Trader sentiment reflects these verified case trajectories and epidemiological patterns rather than projections.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Wolumen
$7,637Data zakończenia
Aug 31, 2026Rynek otwarty
Jul 31, 2026, 12:30 PM ETResolver
0x65070BE91...As of August 6, 2026, the CDC has confirmed 2,465 measles cases in the United States for the year, already exceeding the full 2025 total of 2,289 and marking the highest annual figure since 1991. Nearly all cases (94%) link to 38 ongoing or extended outbreaks across 47 jurisdictions, driven primarily by transmission among unvaccinated or under-vaccinated individuals amid declining MMR coverage. Recent weekly increments of 24–78 cases indicate steady but not explosive growth, with geographic spread in states like Utah, Arizona, and others sustaining momentum through August. CDC surveillance updates, typically released mid-week, along with any new outbreak declarations, will provide the key data points influencing final tallies by the August 31 resolution window. Trader sentiment reflects these verified case trajectories and epidemiological patterns rather than projections.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania